Enhanced antitumor effects of follicle-stimulating hormone receptor-mediated hexokinase-2 depletion on ovarian cancer mediated by a shift in glucose metabolism

BACKGROUND: Most cancers favor glycolytic-based glucose metabolism. Hexokinase-2 (HK2), the first glycolytic rate-limiting enzyme, shows limited expression in normal adult tissues but is overexpressed in many tumor tissues, including ovarian cancer. HK2 has been shown to be correlated with the progr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Meng, Liu, Qiyu, Zhang, Mingxing, Cao, Cong, Liu, Xiaoxia, Zhang, Mengyu, Li, Guiling, Xu, Congjian, Zhang, Xiaoyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648390/
https://www.ncbi.nlm.nih.gov/pubmed/33160373
http://dx.doi.org/10.1186/s12951-020-00720-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648390/
https://www.ncbi.nlm.nih.gov/pubmed/33160373
http://dx.doi.org/10.1186/s12951-020-00720-4

Ejemplares similares